74 results
8-K
EX-10.1
INMB
INmune Bio Inc
13 Jun 24
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.2
INMB
INmune Bio Inc
16 May 24
Departure of Directors or Certain Officers
4:00pm
8-K
EX-10.1
INMB
INmune Bio Inc
16 May 24
Departure of Directors or Certain Officers
4:00pm
8-K
EX-10.1
INMB
INmune Bio Inc
26 Apr 24
INmune Bio Inc. Announces $9.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:28pm
8-K
EX-10.2
INMB
INmune Bio Inc
26 Apr 24
INmune Bio Inc. Announces $9.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:28pm
8-K
EX-10.3
sdtvm7ldy
22 Apr 24
Entry into a Material Definitive Agreement
5:10pm
8-K
EX-10.1
oksi87q56 cszq
22 Apr 24
Entry into a Material Definitive Agreement
5:10pm
8-K
EX-10.2
qv2h3bump h7jin
22 Apr 24
Entry into a Material Definitive Agreement
5:10pm
8-K
EX-10.1
lwjct6 nga33s
1 Jun 23
Departure of Directors or Certain Officers
4:00pm
8-K
EX-10.2
a4j5n ocvs3a
20 Apr 23
XPro1595 Improves Outcomes in a Mouse Model of TBI-induced Alzheimer’s Disease
4:30pm
8-K
EX-10.1
ewi515
20 Apr 23
XPro1595 Improves Outcomes in a Mouse Model of TBI-induced Alzheimer’s Disease
4:30pm
8-K
EX-10.1
de6j1vyfmsyzg pc7cf
24 Mar 22
Departure of Directors or Certain Officers
4:01pm
8-K
EX-10.2
mg0p0hfh s8
24 Mar 22
Departure of Directors or Certain Officers
4:01pm
8-K
EX-10.1
bi3 jy0kzwfeeqtar
24 Mar 22
Entry into a Material Definitive Agreement
4:00pm
8-K
EX-10.1
52sc0w
15 Sep 21
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
ylc ggae3x
15 Jul 21
Inmune Bio, Inc. Announces $40 Million
4:41pm
8-K
EX-10.2
h2lfw
15 Jul 21
Inmune Bio, Inc. Announces $40 Million
4:41pm
8-K
EX-10.1
ydo17pd1sr7e09p
24 Jun 21
Departure of Directors or Certain Officers
4:40pm
8-K
EX-10.2
hq98gk3
24 Jun 21
Departure of Directors or Certain Officers
4:40pm
8-K
EX-10.5
k1a qhii9b
15 Jun 21
INmune Bio, Inc. Announces $15 Million Credit Facility to Purchase Xencor Option to Reduce Future Dilution
4:03pm